Experimental cancer drugs have been found to help some patients avoid surgery, with one treatment showing potential to shrink tumors. The drugs have reportedly had significant results in trials for pancreatic cancer, with some outlets describing the outcomes as unprecedented or a game changer. However, it is unclear if these specific results apply to all the experimental cancer drugs being tested, as reports also mention varying types of cancer and treatments being researched.